MedTrace Logo

Intravenous Lidocaine and Quality of Recovery After Cesarean Delivery

NCT02257346 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-06-09

No results posted yet for this study

Summary

When given intravenously, the local anesthetic lidocaine has been shown to decrease the amount of pain medication patients require when recovering from several types of surgeries. Cesarean delivery is a very common surgery in the United States, effecting more than 1 million women each year. The investigators hypothesize that lidocaine, given during and immediately after a patient undergoes a cesarean section, will help improve a mother's overall recovery experience, as well as positively influence bonding with her new baby.

Conditions

  • Pregnancy

Interventions

DRUG

Lidocaine

Lidocaine infusion will be administered immediately after delivery of the fetus and continue through 1 hour into recovery period.

DRUG

Normal Saline

Normal Saline will be administered as a placebo immediately after delivery of the fetus and continue through 1 hour into recovery period

Sponsors & Collaborators

Principal Investigators

  • Jason R Farrer, M.D. · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2015-02-15
Completion
2015-02-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02257346 on ClinicalTrials.gov